Long-term expansion, genomic stability and in vivo safety of adult human pancreas organoids.
Nikitas GeorgakopoulosNicole PriorBrigitte AngresGianmarco MastrogiovanniAlex CaganDaisy HarrisonChristopher J HindleyRobert Arnes-BenitoSiong-Seng LiauAbbie CurdNatasha IvoryBenjamin D SimonsInigo MartincorenaHelmut WurstKourosh Saeb-ParsyMeritxell HuchPublished in: BMC developmental biology (2020)
hPOs can be expanded long-term, from both fresh and cryopreserved human pancreas tissue in a chemically defined, serum-free medium with no detectable tumorigenicity. hPOs can be clonally expanded, genetically manipulated and are amenable to culture in a chemically defined hydrogel. hPOs therefore represent an abundant source of pancreas ductal cells that retain the characteristics of the tissue-of-origin, which opens up avenues for modelling diseases of the ductal epithelium and increasing understanding of human pancreas exocrine biology as well as for potentially producing insulin-secreting cells for the treatment of diabetes.
Keyphrases
- endothelial cells
- induced apoptosis
- induced pluripotent stem cells
- type diabetes
- pluripotent stem cells
- cell cycle arrest
- cardiovascular disease
- glycemic control
- signaling pathway
- metabolic syndrome
- adipose tissue
- young adults
- mesenchymal stem cells
- cell proliferation
- dna methylation
- insulin resistance
- smoking cessation